Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Alterations in Muscle Tone lll

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.

Molecular cancer·2018

Same author

Association of TERT rs2736098 polymorphism with cancer risk: a meta-analysis.

Asian Pacific journal of cancer prevention : APJCP·2012

Same author

Generation of polyfluoroaryl-fused H-pyrazolo[5,1-a]isoquinolines through a reaction of N'-(2-alkynylbenzylidene)hydrazide with polyfluoroarene.

Chemistry, an Asian journal·2012

Same author

Cooperation of protease-activated receptor 1 and integrin ανβ5 in thrombin-mediated lung cancer cell invasion.

Oncology reports·2012

Same author

α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation.

Journal of neuroinflammation·2012

Same author

An unexpected silver triflate catalyzed reaction of 2-alkynylbenzaldehyde with 2-isocyanoacetate.

Organic letters·2012

Search research articles

Related Experiment Video

Updated: Jun 5, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

Parkinson's disease in China.

You-yong Tian¹, Cui-ju Tang, Jie Wu

¹Department of Neurology, The Affiliated Nanjing First Hospital of Nanjing Medical University, Nanjing, 210006, People's Republic of China. tyy9956@163.com

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

|December 22, 2010

Summary

Parkinson's disease (PD) research in China has advanced significantly, covering epidemiology, causes, diagnosis, and management. Despite progress, a gap remains compared to Western countries, highlighting areas for future development in PD studies.

Related Experiment Videos

Last Updated: Jun 5, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

Area of Science:

Neurology
Medical History
Public Health

Background:

Parkinson's disease (PD), or paralysis agitans, was first described in 1817.
Early clinical manifestations of PD were noted in ancient Chinese medical texts over 2000 years ago.
PD research in China has gained substantial attention in the last 30 years.

Purpose of the Study:

To review the progress in Parkinson's disease research within China.
To focus on key areas including epidemic characteristics, etiology, diagnosis, and management of PD in the Chinese context.

Main Methods:

Literature review of recent studies on Parkinson's disease in China.
Analysis of research progress in epidemiology, etiology, diagnosis, and management.

Main Results:

Significant advancements have been made in understanding Parkinson's disease in China.
Progress spans across the epidemic characteristics, etiological factors, diagnostic methods, and management strategies for PD.
A notable gap persists between Chinese and Western research in Parkinson's disease.

Conclusions:

Chinese scholars have made considerable progress in Parkinson's disease research.
Further efforts are needed to bridge the gap with Western research in PD.
Continued focus on epidemiology, etiology, diagnosis, and management is crucial for advancing PD care in China.